 |
|
New technology makes clinical research more precise
December 12, 2006Ghent, Belgium - The Flanders Interuniversity Institute for Biotechnology (VIB) and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans. The collaboration between VIB and AlgoNomics has yielded a biological test that supplements the current computer simulations. The additional data enable a more precise determination of the immune response. This knowledge is important for the development of new medicines, because it indicates that a new therapeutic substance is ready to be tested on humans.
T-cells, essential agents of our immune system
The immune system is our defense against foreign intruders, such as viruses and bacteria. It reacts against everything that it recognizes as 'foreign to the body'-but, therefore, it might also react against certain substances that researchers want to develop into therapeutic drugs. An important trigger of the immune system's response is the activation of T-cells, a particular type of white blood cell. The T-cells produce cytokines, substances that signal the other cells of the immune system to take action.
Developing therapeutic proteins
In the development of new therapeutic proteins, it is extremely important to know whether or not the proteins induce an immune response. When you suspect that a certain substance has a therapeutic effect, it must not be destroyed by your immune system, or induce other immune responses, because you want the substance to be able to do its beneficial work.
On the other hand, when developing a vaccine, you do want it to induce an immune response-that is, a reaction that does not make you sick but that protects you against future contact with the disease that the vaccine combats.
Epibase®, an 'in silico' test
For quite some time now, AlgoNomics has been offering Epibase® to companies that are developing therapeutic proteins and that want to know whether their product induces an immune response. On the basis of a sophisticated computer program, Epibase® can predict whether or not a particular protein will trigger the activation of T-cells. The technology can do this for all proteins, whether they originate from humans or from another biological source, such as a virus or a cancer cell. The marvelous thing about Epibase® is that it can also do this for proteins for which little or no experimental data are available. Other technologies require at least a minimum of data to predict whether a substance induces an immune response or not. Epibase® has already been used for the development of a variety of therapeutic proteins and is currently the biotech industry standard. In contrast to other 'in silico' platforms, Epibase® provides greater precision and can predict immune response in Asian and South American populations as well.
A more complete test
Upon the request of AlgoNomics, VIB scientists connected with Ghent University, under the direction of Johan Grooten, have designed a biological test that supplements the Epibase® assessments with certain experimental data. The test exposes blood cells-which include T-cells-to the proteins under study. If the proteins being investigated induce an immune response, the T-cells will become active and produce cytokines. In this new test, the activity of the T-cells is measured by determining the quantity of cytokines that are produced.
The new test allows scientists to examine a biological system to see whether a substance induces an immune response. For the step to a clinical phase (and thus tests on humans), the experimental and 'in silico' data are both needed to assess the risk of inducing an immune response. Thanks to the collaboration between VIB and AlgoNomics, it is now possible to generate all the data by means of a single test-an artful combination of 'in silico' and 'in vitro' work.
VIB, Flanders Interuniversity Institute of Biotechnology
In the development of new therapeutic proteins, it is extremely important to know whether or not the proteins induce an immune response. When you suspect that a certain substance has a therapeutic effect, it must not be destroyed by your immune system, or induce other immune responses, because you want the substance to be able to do its beneficial work.
On the other hand, when developing a vaccine, you do want it to induce an immune response-that is, a reaction that does not make you sick but that protects you against future contact with the disease that the vaccine combats.
Epibase®, an 'in silico' test
For quite some time now, AlgoNomics has been offering Epibase® to companies that are developing therapeutic proteins and that want to know whether their product induces an immune response. On the basis of a sophisticated computer program, Epibase® can predict whether or not a particular protein will trigger the activation of T-cells. The technology can do this for all proteins, whether they originate from humans or from another biological source, such as a virus or a cancer cell. The marvelous thing about Epibase® is that it can also do this for proteins for which little or no experimental data are available. Other technologies require at least a minimum of data to predict whether a substance induces an immune response or not. Epibase® has already been used for the development of a variety of therapeutic proteins and is currently the biotech industry standard. In contrast to other 'in silico' platforms, Epibase® provides greater precision and can predict immune response in Asian and South American populations as well.
A more complete test
Upon the request of AlgoNomics, VIB scientists connected with Ghent University, under the direction of Johan Grooten, have designed a biological test that supplements the Epibase® assessments with certain experimental data. The test exposes blood cells-which include T-cells-to the proteins under study. If the proteins being investigated induce an immune response, the T-cells will become active and produce cytokines. In this new test, the activity of the T-cells is measured by determining the quantity of cytokines that are produced.
The new test allows scientists to examine a biological system to see whether a substance induces an immune response. For the step to a clinical phase (and thus tests on humans), the experimental and 'in silico' data are both needed to assess the risk of inducing an immune response. Thanks to the collaboration between VIB and AlgoNomics, it is now possible to generate all the data by means of a single test-an artful combination of 'in silico' and 'in vitro' work.
VIB, Flanders Interuniversity Institute of Biotechnology
Clinical Research Current Events and Clinical Research News RSSAmid the flu epidemic, don't forget RSV in young children
Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public.
Genetic analysis helps dissect molecular basis of cardiovascular disease
Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study.
Effect of real-time CPR feedback reported at resuscitation science symposium
Emergency medical service (EMS) providers in the United States assess an estimated 350,000 cardiac arrests each year. Only 5 to 10 percent of people who have sudden cardiac arrest survive. Better quality cardiopulmonary resuscitation (CPR) provided by prehospital EMS providers may be associated with better patient outcome.
UCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
Researchers mobilizing global resources to test new treatments for severe H1N1 infection
An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.
Expectant moms, babies subjects of new Singapore study to prevent obesity and diabetes in adults
Three Singapore biomedical institutions have launched a major, long-term study of pregnant mothers and their fetuses as well as infant children to determine just how profoundly environmental factors early in life influence the onset of diseases such as obesity and diabetes in later years.
NHLBI stops enrollment in study on resuscitation methods for cardiac arrest
Enrollment has ended early in a large, multicenter clinical trial comparing two distinct resuscitation strategies delivered by emergency medical service (EMS) providers to increase blood flow during cardiac arrest.
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
Newly revised guidelines for managing thyroid cancer published in Thyroid journal
The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer.
More Clinical Research Current Events and Clinical Research News Articles
 |
Foundations of Clinical Research: Applications to Practice (3rd Edition) by Leslie Gross Portney (Author), Mary P. Watkins (Author) Provides the foundations that are necessary for finding and interpreting research evidence across all healthcare professions. Revised to reflect the most current changes in the field of clinical research in rehabilitation and medicine, including the growing emphasis on evidence-based practice (EBP) that has become central to all of health care and the new vocabulary that is being integrated into research and practice across disciplines. There is also a new chapter on systematic reviews and meta-analysis as well as expanded content related to clinical decision making, including likelihood ratios, pretest and posttest probabilities, minimally important change and number needed to treat. For those in the health professions, including physical therapy,... |
 |
Conducting Clinical Research: A Practical Guide for Physicians, Nurses, Study Coordinators, and Investigators by Judy Stone (Author) In Conducting Clinical Research: A Practical Guide for Physicians, Nurses, Study Coordinators, and Investigators, you will discover how to Attract drug companies to your site Land a study on good terms Recruit patient volunteers --- and keep them happy! Implement easy strategies for coordinating studies Organize your clinical trial activities Demystify regulatory requirements
|
 |
Designing Clinical Research: An Epidemiologic Approach by Stephen B Hulley (Author), Steven R Cummings (Author), Warren S Browner (Author), Deborah G Grady (Author), Thomas B Newman (Author) Designing Clinical Research sets the standard for providing a practical guide to planning, tabulating, formulating, and implementing clinical research, with an easy-to-read, uncomplicated presentation. This edition incorporates current research methodology--including molecular and genetic clinical research--and offers an updated syllabus for conducting a clinical research workshop. Emphasis is on common sense as the main ingredient of good science. The book explains how to choose well-focused research questions and details the steps through all the elements of study design, data collection, quality assurance, and basic grant-writing. All chapters have been thoroughly revised, updated, and made more user-friendly. "Doody's Core Titles™ 2009." |
 |
Principles and Practice of Clinical Research, Second Edition (Principles & Practice of Clinical Research) by John I. Gallin (Editor), Frederick P. Ognibene (Editor), Frederick P Ognibene (Editor) The second edition of this innovative work again provides a unique perspective on the clinical discovery process by providing input from experts within the NIH on the principles and practice of clinical research. Molecular medicine, genomics, and proteomics have opened vast opportunities for translation of basic science observations to the bedside through clinical research. As an introductory reference it gives clinical investigators in all fields an awareness of the tools required to ensure research protocols are well designed and comply with the rigorous regulatory requirements necessary to maximize the safety of research subjects. Complete with sections on the history of clinical research and ethics, copious figures and charts, and sample documents it serves as an excellent companion... |
 |
The CRC's Guide to Coordinating Clinical Research by Karen E. Woodin (Author), Ph.D. (Author), Sara Gambrill (Editor) The CRC's Guide to Coordinating Clinical Research is a comprehensive training resource for investigative site staff. This invaluable guide offers CRCs the information they need to successfully coordinate a clinical trial from study startup to closeout and beyond. Topics covered include: *Developing standard operating procedures (SOPs) *Recruiting and retaining study subjects *Understanding the informed consent process *Working with protocols and case report forms *Recognizing adverse events *Preparing for audits The CRC's Guide to Coordinating Clinical Research is recommended for: *Novice and experienced CRCs *Professionals interested in getting involved with clinical research at the investigative site level *Investigative site... |
 |
Clinical Research: What It Is and How It Works by Lori A. Nesbitt (Author) Hardly a week goes by without a newspaper headline or an evening news report detailing a mishap or scandal in the world of clinical research. An increasingly informed public demands speedy breakthroughs in treatment while eyeing warily the risks of participation in clinical trials. The nation’s most prestigious medical centers suffer record fines for research misconduct and the embarrassment that goes with it. Against this backdrop those in the trenches of clinical research work under heightening pressure and scrutiny. More than ever this field demands an unprecedented level of knowledge and understanding. Clinical Research: What It Is and How It Works will provide you with a fundamental yet comprehensive understanding of all phases of the clinical research process. Every aspect... |
 |
The CRA's Guide to Monitoring Clinical Research :2nd Edition by Karen E. Woodin (Author), Ph.D. (Author), John C. Schneider (Author), Sara Gambrill (Editor), Steve Zisson (Editor) The CRA's Guide to Monitoring Clinical Research is a comprehensive and practical educational resource for both the novice and experienced CRA. This newly updated training tool provides essential information on the clinical research process, regulations, role responsibilities, helpful hints and personal experiences. This guide also teaches CRAs to demonstrate how regulations, GCPs and SOPs can be applied to everyday operations of conducting and monitoring clinical trials. Topics covered include: *The history behind the regulations *Clinical study preparation *The informed consent process *Adverse events and safety monitoring *Recruitment, retention and compliance of study subjects *Errors, misconduct and fraud *The future of CRAs and more The CRA's Guide... |
 |
Clinical Research: Concepts and Principles for Advanced Practice Nurses by Manfred Stommel (Author), Celia E Wills (Author) Michigan State Univ., East Lansing. Designed to equip nurses with a thorough understanding of the methodological concepts and tools used in evidence-based clinical practice. Provides basic skills in interpreting and using research for the clinical management of patient populations. Specifically written for graduate nursing students. Softcover. |
 |
Clinical and Translational Science: Principles of Human Research by David Robertson (Editor), Gordon H. Williams (Editor) Clinical and translational science are fields devoted to investigating human health and disease, interventions, and outcomes for the purposes of developing new treatment approaches, devices, and modalities to improve health. New molecular tools and diagnostic technologies based on clinical and translational research have lead to a better understanding of human disease and the application of new therapeutics for enhanced health. This book is designed as the most authoritative and up-to-date resource for the broad range of investigators in various medical specialties taking on the challenge of clinical and translational science. Prepared with an international perspective, Clinical and Translational Science begins with experimental design and investigative tools to set the scene for... |
 |
Publishing and Presenting Clinical Research, Second Edition by Warren S Browner (Author) This book is an excellent practical primer for researchers who wish to learn how to organize, present, and publish the results of their research. Written in a crystal-clear style with numerous examples, tables, and figures, the book shows how to produce a successful abstract, poster and/or manuscript for publication. This updated edition reflects the growing use of software in preparing and submitting presentations and publications. The posters and oral presentations chapters have been completely rewritten to cover PowerPoint technology. Emphasis is placed on learning how to create graphics for written research. This edition also includes new clinical examples. |
| © 2009 BrightSurf.com |